FASLG and atherosclerosis: Treatment of these patients with corticosteroids result in an increase in low-density lipoproteins (LDLs) and triglycerides in the body which could then further accelerate the process of atherosclerosis.17–18 Moreover, the aPL antibodies found in these patients could potentially cross-react with antibodies against oxidized LDL due to similarities between cardiolipin, β2 glycoprotein I, and LDL molecules.